2015
Alzheimer’s disease is a progressive neurodegenerative disease that typically manifests clinically as an isolated amnestic deficit that progresses to a (…)
Consulter 
2015
Measurement of synaptic activity by Positron Emission Tomography (PET) and its relation to cognitive functions such as episodic memory, working (…)
Consulter
2015
The large majority of neuroimaging studies in Alzheimer’s disease (AD) patients have supported the idea that lifestyle factors may protect (…)
Consulter
2015
Subjective cognitive decline (SCD) may be the first clinical sign of Alzheimer’s disease (AD). SCD individuals with normal cognition may (…)
Consulter
2015
Research increasingly suggests that subjective cognitive decline (SCD) in older adults, in the absence of objective cognitive dysfunction or depression, (…)
Consulter
2015
To examine interactions between years of education and APOE ε4 status on gray matter volume and metabolism in cognitively healthy (…)
Consulter
